seastarmedical.comFighting the Cytokine Storm | SeaStar Medical

The Problem Our Solution QUELimmune PIPELINE About Investors News Contact Menu The Problem Our Solution QUELimmune PIPELINE About Investors News Contact Making waves. Changing outcomes. With our simple approach to addressing a key source of a dysregulated immune response, SeaStar Medical is advancing the science of cell-directed extracorporeal therapy to prevent the devastation of hyperinflammation chart a new course Patented technology that transforms key inflammatory messengers from agents of destruction to agents of repair Improve patient outcomes Enables you to alter patients’ disease progression and put them on the path to healing Keep workflow on track Seamlessly integrates into your critical-care workflow Giving you the power to defeat a serious clinical threat Critically ill patients in the ICU often face an alarming, urgent situation. A dangerous, dysregulated hyperinflammatory response to infection, trauma or surgery can lead to multiorgan failure and in severe cases, even death. SeaStar Medical is an innovator with groundbreaking solutions that give you the power to stop this serious threat before it can do irreparable harm to the patients you are fighting for. Backed by rigorous clinical research and robust scientific evidence, our patented approach is designed to support your clinical end goals including reducing dialysis dependency, improving outcomes, and saving precious lives. The game-changing selective cytopheretic device (SCD) With SeaStar Medical’s novel, simple-to-use SCD technology, you can quickly rescue patients from this dysregulated immune response to restore immune balance and help the body return toward homeostasis. Learn more about quelimmune Better outcomes A shorter treatment regimen to reach the desired effect may reduce dependency on dialysis and time in the ICU. This can help put patients on the road back to recovery sooner and free up resources more quickly. Contact Us SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies provide life-saving solutions to critically ill patients. We are developing and commercializing cell-directed extracorporeal therapies that target the key immune cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Problem Our Solution QUELimmune PIPELINE About Investors News Contact The Problem Our Solution QUELimmune PIPELINE About Investors News Contact Privacy Policy Terms and Conditions Privacy Policy Terms and Conditions Address: 3513 Brighton Blvd Suite 410 Denver, CO 80216 Phone: 844-427-8100 Email: info@seastarmed.com Follow Us: LinkedIn Twitter ©SeaStar Medical...